Anti-Obesity Agents Should Be Eligible For Diabetes Indication - Cmte.
Executive Summary
Anti-obesity drugs which reduce body fat and improve glycemic control may be granted a primary diabetic indication, an FDA Advisory Committee suggested March 12.